Director, R&D
Lonza, France
Dr. HDR Vincent Jannin is currently the Director of R&D and Head of Innovaform™ Accelerator - the innovation and formulation accelerator at Lonza Capsules & Health Ingredients. In this role, he founded and leads the lab, assembling a multidisciplinary team and overseeing the construction of a state-of-the-art facility to foster co-innovation with customers. Dr. Jannin develops and implements strategic plans to drive business growth and support team development. He has been instrumental in launching and commercializing new products, providing advanced characterization and formulation insights, including the award-winning Capsugel® Enprotect® capsule. He maintains strong scientific connections with customers, overseeing the development of proof-of-concept capsules and formulations to address delivery challenges. Additionally, he has established himself as a thought leader in oral lipid-based formulation and capsule innovation through presentations at international conferences and peer-reviewed publications.
Previously, Dr. Jannin held various positions at Gattefossé from 1998 to 2018, culminating as Research Director - Pharmaceuticals. He also served as a lecturer at Lyon University (CPE Lyon) from 2003 to 2019, where he taught formulation sciences. He earned his Pharm.D. (1999) and Ph.D. (2004) from the University of Bourgogne, focusing on pharmaceutical technologies. In 2010, he achieved the HDR (Habilitation to Supervise Research) from the University of Lyon, specializing in advanced drug delivery systems. The HDR is the highest academic qualification in France, recognizing superior independent scholarly accomplishments.
Dr. Jannin has a distinguished publication record, including 72 peer-reviewed journal articles (h-index=39), 5 patent families, 5 book chapters, 81 meeting abstracts, and 71 lectures on Drug Delivery Systems.